Inhibiting B cells enhances the efficacy of STING agonism or immune checkpoint blockade in hepatocellular carcinoma
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
Research suggests that inhibiting B cells may improve the effectiveness of certain treatments for hepatocellular carcinoma, specifically STING agonism and immune checkpoint blockade. This approach appears to enhance the efficacy of these treatments in addressing the disease. The findings indicate a potential therapeutic strategy for hepatocellular carcinoma.